Penumbra (PEN) Return on Capital Employed Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 362.00 |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 987.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 987.00 |
| Dec 31, 2025 | 1,130.00 |
| Sep 30, 2025 | 1,449.00 |
| Jun 30, 2025 | 1,382.00 |
| Mar 31, 2025 | 486.00 |
| Dec 31, 2024 | 145.00 |
| Mar 31, 2024 | 911.00 |
| Dec 31, 2023 | 1,088.00 |
| Sep 30, 2023 | 719.00 |
| Jun 30, 2023 | 184.00 |
| Mar 31, 2023 | -494.00 |
| Dec 31, 2022 | -815.00 |
| Sep 30, 2022 | -1,176.00 |
| Jun 30, 2022 | -496.00 |
| Mar 31, 2022 | -351.00 |
| Dec 31, 2021 | -57.00 |
| Mar 31, 2021 | -530.00 |
| Dec 31, 2020 | -576.00 |
| Sep 30, 2020 | -288.00 |
| Jun 30, 2020 | 256.00 |
| Mar 31, 2020 | 802.00 |
| Dec 31, 2019 | 916.00 |
| Sep 30, 2019 | 785.00 |
| Jun 30, 2019 | -16.00 |
| Mar 31, 2019 | 46.00 |
| Dec 31, 2018 | -198.00 |